U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931691) titled 'A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China' on March 14.

Brief Summary: The implementation of new standards for the management of PNH and the use of iptacopan in patients with PNH are expected to change the treatment landscape and improve the overall prognosis of patients.

Based on these backgrounds, we plan to conduct a real-world study of iptacopan to further evaluate its impact on treatment-related outcomes, disease management, and healthcare resource utilization in Chinese patients with PNH.

Study Start Date: April 30

Study Type: OBSERVATIONAL

Condition...